Publication | Open Access
Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer’s disease
93
Citations
40
References
2015
Year
Synaptic TransmissionMolecular BiologyAlzheimer ’Synaptic SignalingCellular NeurobiologySocial SciencesAlzheimer's DiseaseSynaptic NeuroscienceCell SurfaceSynapse LossDegenerative PathologyProtein MisfoldingNeurologyAd HippocampusMolecular SignalingMolecular NeuroscienceAβ-dependent ReductionNeurodegenerationCell BiologyProtective MechanismsNeurodegenerative DiseasesSynaptic PlasticityCellular NeuroscienceNeuroscienceSynaptic DysfunctionMolecular NeurobiologyMedicine
Alzheimer's disease (AD) is characterized by synapse loss due to mechanisms that remain poorly understood. We show that the neural cell adhesion molecule 2 (NCAM2) is enriched in synapses in the human hippocampus. This enrichment is abolished in the hippocampus of AD patients and in brains of mice overexpressing the human amyloid-β (Aβ) precursor protein carrying the pathogenic Swedish mutation. Aβ binds to NCAM2 at the cell surface of cultured hippocampal neurons and induces removal of NCAM2 from synapses. In AD hippocampus, cleavage of the membrane proximal external region of NCAM2 is increased and soluble extracellular fragments of NCAM2 (NCAM2-ED) accumulate. Knockdown of NCAM2 expression or incubation with NCAM2-ED induces disassembly of GluR1-containing glutamatergic synapses in cultured hippocampal neurons. Aβ-dependent disassembly of GluR1-containing synapses is inhibited in neurons overexpressing a cleavage-resistant mutant of NCAM2. Our data indicate that Aβ-dependent disruption of NCAM2 functions in AD hippocampus contributes to synapse loss.
| Year | Citations | |
|---|---|---|
Page 1
Page 1